HLS and Harlan Laboratories Announce Joint Presence at SOT 2015
Complete the form below to unlock access to ALL audio articles.
Huntingdon Life Sciences (HLS) and Harlan Laboratories arrive at the Society of Toxicology’s (SOT) annual meeting with their integration plans progressing well and nearing completion.
Over the past nine months, the two companies have successfully integrated their operations and commercial and management organizations across their global footprint.
“At SOT 2015, we very much look forward to discussing our progress and achievements across the integration process with our customers and the wider market. We believe that our combined company offers increased value by giving customers access to our broader product and service offering, a greater geographic reach, and through our scientific and technical excellence. Indeed, our customers are actively engaging with us to learn more about how they can best leverage our increased capabilities,” commented Adrian Hardy, Chief Operational Officer of the combined Huntingdon and Harlan organizations.
Huntingdon and Harlan Laboratories have an extensive programme of activity in place at the meeting. This includes the publication of 12 posters displaying scientific data on new methods and assays that directly benefit those involved in drug development and agrochemical assessment.
Furthermore, they are presenting at three hour long sessions on multiple themes including: The immunology of immunogenicity? Less compound, less cost - How to succeed in early-phase inhalation programs and Advances in in vitro and in silico techniques: Regulatory acceptance worldwide”.
